Tissue Regenix Group Plc (TRX) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.007x

Based on the latest financial reports, Tissue Regenix Group Plc (TRX) has a cash flow conversion efficiency ratio of -0.007x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-202.00K ≈ $-24.58 USD) by net assets (GBX28.62 Million ≈ $3.48K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See net asset quality index of Tissue Regenix Group Plc to measure how much of total assets are equity-financed.

Tissue Regenix Group Plc - Cash Flow Conversion Efficiency Trend (2008–2024)

This chart illustrates how Tissue Regenix Group Plc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check TRX cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Tissue Regenix Group Plc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tissue Regenix Group Plc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Accentro Real Estate AG F:A4Y	0.064x
Shapeways Holdings, Inc NASDAQ:SHPWQ	-0.202x
Meta Materials Inc. NASDAQ:MMATQ	-0.323x
Ordinary Fully Paid Deferred Settlement AU:BPPDD	0.140x
China New Higher Education Group Limited STU:8CN	0.002x
Ordinary Fully Paid Deferred Settlement AU:GMNDA	N/A
Isomet Corp NASDAQ:IOMT	0.073x
Edgio, Inc. NASDAQ:EGIOQ	-0.070x

Annual Cash Flow Conversion Efficiency for Tissue Regenix Group Plc (2008–2024)

The table below shows the annual cash flow conversion efficiency of Tissue Regenix Group Plc from 2008 to 2024. For the full company profile with market capitalisation and key ratios, see TRX market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	GBX29.06 Million ≈ $3.54K	GBX-1.64 Million ≈ $-198.93	-0.056x	-258.83%
2023-12-31	GBX29.36 Million ≈ $3.57K	GBX1.04 Million ≈ $126.54	0.035x	+169.20%
2022-12-31	GBX25.27 Million ≈ $3.08K	GBX-1.29 Million ≈ $-157.44	-0.051x	+57.57%
2021-12-31	GBX24.65 Million ≈ $3.00K	GBX-2.98 Million ≈ $-361.97	-0.121x	+44.50%
2020-12-31	GBX27.85 Million ≈ $3.39K	GBX-6.05 Million ≈ $-736.72	-0.217x	+24.13%
2019-12-31	GBX24.59 Million ≈ $2.99K	GBX-7.05 Million ≈ $-857.66	-0.287x	-37.96%
2018-12-31	GBX32.57 Million ≈ $3.96K	GBX-6.77 Million ≈ $-823.23	-0.208x	+16.10%
2018-01-31	GBX39.52 Million ≈ $4.81K	GBX-9.79 Million ≈ $-1.19K	-0.248x	-0.48%
2017-12-31	GBX39.52 Million ≈ $4.81K	GBX-9.74 Million ≈ $-1.18K	-0.246x	+73.43%
2016-12-31	GBX11.54 Million ≈ $1.40K	GBX-10.70 Million ≈ $-1.30K	-0.927x	-121.78%
2016-01-31	GBX30.25 Million ≈ $3.68K	GBX-12.65 Million ≈ $-1.54K	-0.418x	+40.36%
2015-01-31	GBX11.58 Million ≈ $1.41K	GBX-8.12 Million ≈ $-987.60	-0.701x	-135.61%
2014-01-31	GBX31.30 Million ≈ $3.81K	GBX-9.31 Million ≈ $-1.13K	-0.298x	-77.43%
2013-01-31	GBX38.64 Million ≈ $4.70K	GBX-6.48 Million ≈ $-788.51	-0.168x	-119.91%
2012-01-31	GBX43.78 Million ≈ $5.33K	GBX-3.34 Million ≈ $-406.19	-0.076x	+67.87%
2011-01-31	GBX9.84 Million ≈ $1.20K	GBX-2.34 Million ≈ $-284.20	-0.237x	-139.99%
2010-01-31	GBX3.67 Million ≈ $446.11	GBX-362.65K ≈ $-44.12	-0.099x	+29.53%
2009-01-31	GBX3.63 Million ≈ $442.27	GBX-510.22K ≈ $-62.08	-0.140x	-144.13%
2008-01-31	GBX9.68 Million ≈ $1.18K	GBX-556.78K ≈ $-67.74	-0.057x	--

About Tissue Regenix Group Plc

LSE:TRX UK Biotechnology

Market Cap

$628.37

GBX5.16 Million GBX

Market Cap Rank

#31826 Global

#1313 in UK

Share Price

GBX0.07

Change (1 day)

+0.00%

52-Week Range

GBX0.07 - GBX33.00

All Time High

GBX2162.50